×
Back to Agenda
Session 1: What’s New and What’s Hot: Perspective on Pharmacovigilance and Risk Management, A Global Perspective
Session Chair(s)
Marc Poitras, PhD, MBA
Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau, Health Canada, Canada
In this session, representatives from regulatory agencies MHRA, FDA, and Health Canada will discuss the progress of the implementation of new/ongoing national and international initiatives to strengthen pharmacovigilance and risk management activities.
Learning Objective : At the conclusion of this session, participants should be able to:- Discuss a global understanding of the challenges faced and the solutions proposed to address them
Speaker(s)
Mick Foy
Director of Delivery, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker
Marc Mes
Director General, Marketed Health Products Directorate, Health Canada, Canada
Speaker
Robert Ball, MD, MPH, MSc
Deputy Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Speaker
Have an account?